References:
1. Haupt HM, Moore GW, Bauer TW, Hutchins GM. The lung in sickle cell
disease. Chest 1982;81(3):332-337.
2. Sylvester KP, Patey RA, Kassim Z, Rafferty GF, Rees D, Thein SL,
Greenough A. Lung gas transfer in children with sickle cell anaemia.
Respiratory physiology & neurobiology 2007;158(1):70-74.
3. Miller GJ, Serjeant GR. An assessment of lung volumes and gas
transfer in sickle-cell anaemia. Thorax 1971;26(3):309-315.
4. Setty BY, Stuart MJ, Dampier C, Brodecki D, Allen JL. Hypoxaemia in
sickle cell disease: biomarker modulation and relevance to
pathophysiology. The Lancet 2003;362(9394):1450-1455.
5. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH,
Klug PP. Mortality in sickle cell disease–life expectancy and risk
factors for early death. New England Journal of Medicine
1994;330(23):1639-1644.
6. Mondal P, Stefek B, Sinharoy A, Sankoorikal B-J, Abu-Hasan M, Aluquin
V. The association of nocturnal hypoxia and an echocardiographic measure
of pulmonary hypertension in children with sickle cell disease.
Pediatric Research 2019;85(4):506-510.
7. Chambellan A, Dirou S, Ricolleau B, Graveleau J, Masseau A. The value
of diffusing capacity for nitric oxide and carbon monoxide in sickle
cell disease. Eur Respiratory Soc; 2015.
8. Ogilvie C, Forster R, Blakemore WS, Morton J. A standardized breath
holding technique for the clinical measurement of the diffusing capacity
of the lung for carbon monoxide. The Journal of clinical investigation
1957;36(1):1-17.
9. Cotton D, Graham B. Effect of ventilation and diffusion nonuniformity
on DLCO (exhaled) in a lung model. Journal of Applied Physiology
1980;48(4):648-656.
10. Dinakara P, Blumenthal W, Johnston R, Kauffman L, Solnick P. The
effect of anemia on pulmonary diffusing capacity with derivation of a
correction equation. American Review of Respiratory Disease
1970;102(6):965-969.
11. Lacedonia D, Carpagnano GE, Galgano G, Schino P, Correale M,
Brunetti ND, Ventura V, Di Biase M, Barbaro MPF. Usefulness of FVC/DLCO
ratio to stratify the risk of mortality in patients with pulmonary
hypertension. Eur Respiratory Soc; 2016.
12. Hsu VM, Chung L, Hummers LK, Wigley F, Simms R, Bolster M, Silver R,
Fischer A, Hinchcliff ME, Varga J. Development of pulmonary hypertension
in a high-risk population with systemic sclerosis in the Pulmonary
Hypertension Assessment and Recognition of Outcomes in Scleroderma
(PHAROS) cohort study. 2014. Elsevier. p 55-62.
13. Klings ES, Wyszynski DF, Nolan VG, Steinberg MH. Abnormal pulmonary
function in adults with sickle cell anemia. American journal of
respiratory and critical care medicine 2006;173(11):1264-1269.
14. Wall MA, Platt OS, Strieder DJ. Lung function in children with
sickle cell anemia. American Review of Respiratory Disease
1979;120(1):210-214.
15. Matheson MC, Raven J, Johns DP, Abramson MJ, Walters EH.
Associations between reduced diffusing capacity and airflow obstruction
in community-based subjects. Respiratory medicine 2007;101(8):1730-1737.
16. Mondal P, Yirinec A, Midya V, Sankoorikal BJ, Smink G, Khokhar A,
Abu‐Hasan M, Bascom R. Diagnostic value of spirometry vs impulse
oscillometry: A comparative study in children with sickle cell disease.
Pediatric pulmonology 2019;54(9):1422-1430.
17. Koumbourlis AC, Zar HJ, Hurlet-Jensen A, Goldberg MR. Prevalence and
reversibility of lower airway obstruction in children with sickle cell
disease. The Journal of pediatrics 2001;138(2):188-192.
18. Biltagi MA, Bediwy AS, Toema O, Saeed NK. Pulmonary Functions in
Children and Adolescents with Sickle Cell Disease. Pediatric Pulmonology
2020.
19. Macintyre N, Crapo R, Viegi G, Johnson D, Van der Grinten C,
Brusasco V, Burgos F, Casaburi R, Coates A, Enright P. Standardisation
of the single-breath determination of carbon monoxide uptake in the
lung. European Respiratory Journal 2005;26(4):720-735.
20. Larsen GL, Morgan W, Heldt GP, Mauger DT, Boehmer SJ, Chinchilli VM,
Lemanske Jr RF, Martinez F, Strunk RC, Szefler SJ. Impulse oscillometry
versus spirometry in a long-term study of controller therapy for
pediatric asthma. Journal of Allergy and Clinical Immunology
2009;123(4):861-867. e1.
21. Thomas AN, Pattison C, Serjeant GR. Causes of death in sickle-cell
disease in Jamaica. Br Med J (Clin Res Ed) 1982;285(6342):633-635.
22. Hoth KF, Zimmerman ME, Meschede KA, Arnedt JT, Aloia MS. Obstructive
sleep apnea. Sleep and Breathing 2013;17(2):811-817.
23. Ambrusko SJ, Gunawardena S, Sakara A, Windsor B, Lanford L,
Michelson P, Krishnamurti L. Elevation of tricuspid regurgitant jet
velocity, a marker for pulmonary hypertension in children with sickle
cell disease. Pediatric blood & cancer 2006;47(7):907-913.
24. Bishara AJ, Hittner JB. Reducing bias and error in the correlation
coefficient due to nonnormality. Educational and psychological
measurement 2015;75(5):785-804.
25. Chen T, Guestrin C. Xgboost: A scalable tree boosting system. 2016.
p 785-794.
26. Willen SM, Cohen R, Rodeghier M, Kirkham F, Redline SS, Rosen C,
Kirkby J, DeBaun MR. Age is a predictor of a small decrease in lung
function in children with sickle cell anemia. American journal of
hematology 2018;93(3):408-415.
27. Chen L, Gong J, Matta E, Morrone K, Manwani D, Rastogi D, De A.
Pulmonary disease burden in Hispanic and non‐Hispanic children with
sickle cell disease. Pediatric Pulmonology 2020.
28. McLaren A, Klingel M, Behera S, Odame I, Kirby-Allen M, Grasemann H.
Effect of hydroxyurea therapy on pulmonary function in children with
sickle cell anemia. American Journal of Respiratory and Critical Care
Medicine 2017;195(5):689-691.
29. Knight-Madden J, Forrester T, Lewis N, Greenough A. Asthma in
children with sickle cell disease and its association with acute chest
syndrome. Thorax 2005;60(3):206-210.
30. Sheather S. A modern approach to regression with R. Springer Science
& Business Media; 2009.
31. Moreno JJM, Pol AP, Abad AS, Blasco BC. Using the R-MAPE index as a
resistant measure of forecast accuracy. Psicothema 2013;25(4):500-506.
32. Wong T-T. Performance evaluation of classification algorithms by
k-fold and leave-one-out cross validation. Pattern Recognition
2015;48(9):2839-2846.
33. Sylvester KP, Patey R, Milligan P, Dick M, Rafferty G, Rees D, Thein
S, Greenough A. Pulmonary function abnormalities in children with sickle
cell disease. Thorax 2004;59(1):67-70.
34. Semenova E, Kameneva M, Tishkov A, Trofimov V, Novikova L.
Relationship the impulse oscillometry parameters and the lung damage in
idiopathic pulmonary fibrosis patients. Eur Respiratory Soc; 2013.
35. Mehrad B, Burdick MD, Wandersee NJ, Shahir KS, Zhang L, Simpson PM,
Strieter RM, Field JJ. Circulating fibrocytes as biomarkers of impaired
lung function in adults with sickle cell disease. Blood advances
2017;1(24):2217-2224.
36. Anthi A, Machado RF, Jison ML, Taveira-DaSilva AM, Rubin LJ, Hunter
L, Hunter CJ, Coles W, Nichols J, Avila NA. Hemodynamic and functional
assessment of patients with sickle cell disease and pulmonary
hypertension. American journal of respiratory and critical care medicine
2007;175(12):1272-1279.
37. Sylvester KP, Patey RA, Milligan P, Rafferty GF, Broughton S, Rees
D, Thein SL, Greenough A. Impact of acute chest syndrome on lung
function of children with sickle cell disease. The Journal of pediatrics
2006;149(1):17-22.
38. Chen G, Zhang D, Fuchs TA, Manwani D, Wagner DD, Frenette PS.
Heme-induced neutrophil extracellular traps contribute to the
pathogenesis of sickle cell disease. Blood 2014;123(24):3818-3827.
39. Zhang D, Xu C, Manwani D, Frenette PS. Neutrophils, platelets, and
inflammatory pathways at the nexus of sickle cell disease
pathophysiology. Blood 2016;127(7):801-809.
40. Neas LM, Schwartz J. The determinants of pulmonary diffusing
capacity in a national sample of US adults. American journal of
respiratory and critical care medicine 1996;153(2):656-664.